메뉴 건너뛰기




Volumn 164, Issue 3, 2014, Pages 10-11

FDA-approved Next-Generation sequencing system could expand clinical genomic testing: Experts predict MiSeqDx system will make genetic testing more affordable for smaller labs
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; FOOD AND DRUG ADMINISTRATION; GENETIC SCREENING; GENOME ANALYSIS; GENOMICS; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; LABORATORY TEST; LEGAL ASPECT; PRIORITY JOURNAL; REIMBURSEMENT; VALIDATION PROCESS; ECONOMICS; HIGH THROUGHPUT SEQUENCING; METHODOLOGY; NOTE; UNITED STATES;

EID: 84894262939     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36461     Document Type: Article
Times cited : (4)

References (1)
  • 1
    • 84890417231 scopus 로고    scopus 로고
    • First FDA authorization for next-generation sequencer
    • Collins FS, Hamburg MA. 2013. First FDA authorization for next-generation sequencer. N Engl J Med 369:2369-2371.
    • (2013) N Engl J Med , vol.369 , pp. 2369-2371
    • Collins, F.S.1    Hamburg, M.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.